BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2300682)

  • 1. Improvement of the isolation-induced social behavioural deficit involves activation of the 5-HT1B receptors.
    Frances H; Lienard C; Fermanian J
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):91-102. PubMed ID: 2300682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
    Kennett GA; Curzon G
    Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
    Kennett GA; Curzon G
    Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepines impair a behavioral effect induced by stimulation of 5-HT1B receptors.
    Francès H; Khidichian F; Monier C
    Pharmacol Biochem Behav; 1990 Apr; 35(4):841-5. PubMed ID: 1971720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP).
    Kłodzińska A; Jaros T; Chojnacka-Wójcik E; Maj J
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):207-18. PubMed ID: 2775468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
    Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
    Alhaider AA; Ageel AM; Ginawi OT
    Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effect of beta-blocking drugs resulting from the stimulation or the blockade of serotonergic 5-HT1B receptors.
    Frances H; Monier C; Debray M
    Pharmacol Biochem Behav; 1994 Aug; 48(4):965-9. PubMed ID: 7972302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.
    Kennett GA; Whitton P; Shah K; Curzon G
    Eur J Pharmacol; 1989 May; 164(3):445-54. PubMed ID: 2767117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic but not acute antidepressants interfere with serotonin (5-HT1B) receptors.
    Frances H; Khidichian F
    Eur J Pharmacol; 1990 Apr; 179(1-2):173-6. PubMed ID: 2364979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothermia induced by m-trifluoromethylphenylpiperazine or m-chlorophenylpiperazine: an effect mediated by 5-HT1B receptors?
    Maj J; Chojnacka-Wójcik E; Kłodzińska A; Dereń A; Moryl E
    J Neural Transm; 1988; 73(1):43-55. PubMed ID: 2969949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacological profile of 1-(m-(trifluoromethyl) phenyl) piperazine (TFMPP).
    Frances H
    Pharmacol Biochem Behav; 1988 Sep; 31(1):37-41. PubMed ID: 3252258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of the serotonergic compound eltoprazine.
    Ybema CE; Slangen JL; Olivier B; Mos J
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1045-51. PubMed ID: 1532031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural evidence of agonist-like effect of isoteoline at 5-HT1B serotonergic receptors in mice.
    Zhelyazkova-Savova MD; Zhelyazkov DK
    J Pharm Pharmacol; 2003 Jan; 55(1):125-9. PubMed ID: 12625876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiaggressive potency of (-)-penbutolol involves both 5-HT1A and 5-HT1B receptors and beta-adrenoceptors.
    Sánchez C; Arnt J; Moltzen EK
    Eur J Pharmacol; 1996 Feb; 297(1-2):1-8. PubMed ID: 8851159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
    Jenck F; Broekkamp CL; Van Delft AM
    Psychopharmacology (Berl); 1990; 100(3):372-6. PubMed ID: 2107558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats.
    Arnt J
    Pharmacol Toxicol; 1989 Feb; 64(2):165-72. PubMed ID: 2526950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of 5-HT1 receptors in the spinal cord changes substance P-induced behaviour.
    Eide PK
    Neuropharmacology; 1992 Jun; 31(6):541-5. PubMed ID: 1383863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.